Valion Bio, Inc. (VBIO) Form 10-K Annual Reports
Valion Bio, Inc. (VBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VBIO
CIK: 1787740
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Rosenberg Rich Baker Berman, P.A.
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRobert Quick
Audit LocationSomerset, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-3 | 2026-10-16 | — | REGISTRATION STATEMENT | 0001683168-26-007936 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-16 | 2026-11-12 | DEFINITIVE PROXY STATEMENT | 0001683168-26-007932 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-15 | CURRENT REPORT | 0001683168-26-007857 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-14 | CURRENT REPORT | 0001683168-26-007834 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-07 | CURRENT REPORT | 0001683168-26-007709 | View SEC Doc Filr Page |
| S-3 | 2026-10-08 | — | REGISTRATION STATEMENT | 0001683168-26-007707 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-05 | FORM 8-K | 0001437749-26-032107 | View SEC Doc Filr Page |
| DRS | 2026-10-05 | — | DRS Filing | 0001683168-26-007617 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-02 | 2026-10-02 | PRELIMINARY PROXY STATEMENT | 0001683168-26-007588 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-30 | CURRENT REPORT | 0001683168-26-007514 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 Filing | 0001683168-26-007398 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-18 | 4 Filing | 0001683168-26-007396 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-17 | FORM 8-K | 0001683168-26-007300 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-08-27 | 3 Filing | 0001683168-26-007217 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-08-27 | 3 Filing | 0001683168-26-007216 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-04 | — | SCHEDULE 13G/A Filing | 0001753926-26-001726 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-03 | — | SCHEDULE 13D/A Filing | 0001753926-26-001719 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-02 | — | SCHEDULE 13D/A Filing | 0001753926-26-001702 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-27 | FORM 8-K | 0001683168-26-006848 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-27 | — | SCHEDULE 13D/A Filing | 0001753926-26-001647 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-26 | CURRENT REPORT | 0001683168-26-006742 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-24 | — | SCHEDULE 13D/A Filing | 0001753926-26-001610 | View SEC Doc Filr Page |
| RW | 2026-08-24 | — | REGISTRATION WITHDRAWAL REQUEST | 0001683168-26-006676 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-20 | 2026-08-14 | AMENDMENT NO 1 | 0001683168-26-006632 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-19 | — | SCHEDULE 13D/A Filing | 0001753926-26-001562 | View SEC Doc Filr Page |